| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/03/2011 | CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2456507C Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 05/03/2011 | CA2438085C Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 05/03/2011 | CA2425933C Combination of catechin and quercetin for pharmaceutical or dietary use |
| 05/03/2011 | CA2421109C Efficient method for producing compositions enriched in anthocyanins |
| 05/03/2011 | CA2400778C Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
| 05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
| 04/28/2011 | WO2011050319A2 Inhibiting the deleterious effect of anthracyclines |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011049475A1 The new application of 2-pyrrolidone derivatives |
| 04/28/2011 | WO2011049213A1 Fused heterocyclic compound and thrombopoietin receptor activator |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048611A1 Novel fused pyridazine derivatives |
| 04/28/2011 | WO2011048448A1 Animal model for cigarette smoke-induced atherosclerosis and related methods |
| 04/28/2011 | WO2011048409A1 Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2011 | WO2011048350A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | WO2011048201A1 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease |
| 04/28/2011 | WO2011048033A2 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 04/28/2011 | WO2011048032A1 Diazepam derivatives as modulators of chemokine receptors |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011047515A1 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof. |
| 04/28/2011 | WO2011047481A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011027956A3 Extracellular vesicles derived from gram-positive bacteria, and disease model using same |
| 04/28/2011 | WO2011021224A3 Improved process for preparing (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-(tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| 04/28/2011 | WO2010144498A9 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
| 04/28/2011 | WO2010086454A9 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
| 04/28/2011 | WO2008017586A3 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 04/28/2011 | US20110098640 Visual indication of rupture of drug reservoir |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098361 Composition to enhance the bioavailability of curcumin |
| 04/28/2011 | US20110098338 RNA Interference for the Treatment of Heart Failure |
| 04/28/2011 | US20110098334 Novel crystalline form of calcium zofenopril |
| 04/28/2011 | US20110098325 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/28/2011 | US20110098321 Salts of methyl 2-((r)-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3-((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate |
| 04/28/2011 | US20110098311 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | US20110098304 Small molecule inhibitors of PARP activity |
| 04/28/2011 | US20110098300 Compounds Comprising A Cyclobutoxy Group |
| 04/28/2011 | US20110098293 Inhibitors of Protein Tyrosine Kinase Activity |
| 04/28/2011 | US20110098292 New Compounds Useful for Treating CNS Disorders |
| 04/28/2011 | US20110098289 Method for treating obesity |
| 04/28/2011 | US20110098281 Benzenesulfonyl Compounds and the Use Thereof |
| 04/28/2011 | US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110098250 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 04/28/2011 | US20110098243 Ectonucleotidase pyrophosphate/phosphodiesterase-1 (enpp-1) as a target for the treatment of aortic valve stenosis and cardiovascular calcification |
| 04/28/2011 | US20110098237 Methods for inhibiting drug degradation |
| 04/28/2011 | US20110098236 Diamide inhibitors of cytochrome p450 |
| 04/28/2011 | US20110098224 Protein kinase c peptide modulators of angiogenesis |
| 04/28/2011 | US20110098213 Novel peptides for use in the treatment of obesity |
| 04/28/2011 | US20110098212 Cytokine |
| 04/28/2011 | US20110097384 Transdermal drug delivery device including an occlusive backing |
| 04/28/2011 | US20110097350 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
| 04/28/2011 | US20110097330 Novel Gene Disruptions, Compostitions and Methods Relating Thereto |
| 04/28/2011 | US20110097303 Methods and compositions for treating and preventing viral infections |
| 04/28/2011 | US20110097300 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 04/28/2011 | US20110097299 Swellable and degradable microspheres |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | DE102009043260A1 Pyridinyl-imidazolonderivate Pyridinyl-imidazolone derivatives |
| 04/28/2011 | CA2781522A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | CA2781499A1 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease |
| 04/28/2011 | CA2778664A1 Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency |
| 04/28/2011 | CA2777881A1 Pyrazolopyrimidine derivatives |
| 04/28/2011 | CA2777310A1 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 04/28/2011 | CA2776914A1 Diazepan derivatives as modulators of chemokine receptors |
| 04/27/2011 | EP2314694A2 BAFF receptor (BCMA), an immunoregulatory agent |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314600A1 Myocardial peptide, preparation method and uses thereof |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314588A1 Compounds of estrogen-related receptor modulators and the uses thereof |
| 04/27/2011 | EP2314585A1 Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 04/27/2011 | EP2314318A1 CD80 antibody for use in combination with chemotherapeutics to treat B cell malignancies |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2314306A1 Biological pacemaker |
| 04/27/2011 | EP2314300A1 Mixed cell populations for tissue repair and separation technique for cell processing |
| 04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
| 04/27/2011 | EP2313417A1 Angiotensin ii receptor antagonists |
| 04/27/2011 | EP2313399A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors |
| 04/27/2011 | EP2313395A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 04/27/2011 | EP2313374A1 6-substituted isoquinolines and isoquinolinones |
| 04/27/2011 | EP1942985B1 Methods for reducing blood pressure |
| 04/27/2011 | EP1937245B1 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| 04/27/2011 | EP1812112B1 Benzodiazepine derivatives as ROCK kinases inhibitors |
| 04/27/2011 | EP1792985B1 Cell fusion promoter and utilization of the same |
| 04/27/2011 | EP1709052B1 Derivatives of 1,4-diazabicyclo 3.2.1octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1439175B1 Pyrimidine compound and medicinal composition thereof |
| 04/27/2011 | EP1383463B1 Fused thiophene compounds and use thereof in the treatment of chronic pain |
| 04/27/2011 | EP1253966B1 Substances and agents for positively influencing collagen |
| 04/27/2011 | EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 04/27/2011 | CN1981810B Danshen component, preparation, making method and usage |